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Abstract
Background: The major clinical feature in chronic pancreatitis is pain, but the genetic basis of
pancreatic pain in chronic pancreatitis is poorly understood. The transient receptor potential
vanilloid receptor 1 (TRPV1) gene has been associated with pain perception, and genetic variations
in TRPV1 may modify the presence and phenotype of chronic pancreatitis. The aim of our study was
to investigate the genetic variation of TRPV1 in Dutch patients with chronic pancreatitis and healthy
controls.
Methods: We genotyped 4 SNPs (rs222749, rs222747, rs224534 and rs8065080) in 228 chronic
pancreatitis-patients and 207 healthy controls by PCR, followed by restriction-fragment-length-
polymorphism analysis and DNA sequencing. We generated 27 diplotypes and compared
prevalence between patients and controls.
Results: There was no significant difference in allele frequency of the 4 TRPV1 gene SNPs in
patients with chronic pancreatitis and healthy controls. Distribution of diplotypes was not
statistically significantly different between patients and controls.
Conclusion: TRPV1 diplotypes are not associated with chronic pancreatitis.
Background
Chronic pancreatitis is an inflammatory process that leads
to a progressive and irreversible destruction of the pancre-
atic parenchyma. The major presenting clinical feature is
abdominal pain [1]. Some 60-100% of patients report
abdominal pain at a given time during the course of their
disease, with pain duration varying from intermittent to
persistent and pain intensity ranging from mild to disa-
bling [2]. Consequently, patients with chronic pancreati-
tis experience substantial impairments in health-related
quality of life [3]. The mechanism of pancreatitis-induced
pain is unknown [1].
The inter-individual differences in the response of pain
suggest that genetic factors may be involved [2,4,5]. A few
studies suggest the transient receptor potential vanilloid
receptor 1 (TRPV1) gene might be involved in pancreatitis
[6-9]. The TRPV1 receptor is a nonselective calcium per-
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meant cation channel that belongs to the transient recep-
tor potential family (TRP). It is expressed predominantly
in nociceptors that participate in the detection of noxious
chemical and thermal stimuli in the dorsal root ganglia
and peripheral sensory nerve endings [6,7]. Capsaicin, red
pepper, is its natural agonist. Activation of TRPV1 on neu-
rons cause the release of pro-inflammatory neuropeptide
substance P and calcitonine G related peptide (CGRP) in
the dorsal horn of the spinal cord which is critical for
transmitting pain signals from the periphery to the central
nervous system [7]. Substance P then binds to the neuro-
kinin-1 receptor (NK1-R) on endothelial cells and pro-
motes extravasation of plasma and proteins into the
interstitial tissue and neutrophil infiltration, a process
called neurogenic inflammation [10]. There is evidence
that activation of TRPV1 is implicated in chronic pancrea-
titis. In a cerulein-induced pancreatitis model, activation
of TRPV1 on sensory neurons promoted neurogenic pan-
creatic inflammation [10]. This effect was blocked by
administration of the selective TRPV1 antagonist cap-
sazepine. In another experimental chronic pancreatitis
model, pancreatic TRPV1 receptor mediated inward cur-
rents have shown to be greatly enhanced. Moreover, sys-
temic administration of the TRPV1 antagonist SB-366791
markedly reduced both visceral pain behavior and
referred somatic hyperalgesia in rats with chronic pancre-
atitis, but not in control animals [6].
TRPV1 is localized on chromosome 17, and consists of 16
exons [11]. HapMap analysis reveals that there are at least
8 non-synonymous single nucleotide polymorphisms
(SNPs) that have a heterozygosity rate that exceeds 10%.
At least 4 SNPs affect structural domains of TRPV1: p.P91S
(rs222749) affects the intracellular amino terminus of
TRPV1; p.I315 M (rs222747) is localized in the ankyrin
repeat-containing domain which is predicted to play a
role in mediating protein-protein interactions and
homotetramerization of the channel; p.T469I (rs224534)
is predicted to be located in the extracellular loop between
membrane-spanning helices 1 and 2; and p.I585V
(rs8065080) is predicted to reside within membrane-
spanning helix 5 and affects the transmembrane domain
which confers responsiveness to capsaicin (Figure 1).
Apart from structural changes, at least 2 SNPs (p.P91S,
p.I315 M) modify the functional properties of the channel
and induce increased TRPV1 protein expression due to an
increased copy number [6].
Collectively, these data suggest a role for TRPV1 in chronic
pancreatitis, and we hypothesized that TRPV1 could act as
The TRPV1 gene Figure 1
The TRPV1 gene. Genomic organization of the TRPV1 gene with genomic structures, positions of splice junction sites. 
p.P91S (rs222749), p.I315 M (rs222747). p.T469I (rs224534) and p.I585V (rs8065080).
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a modifier for chronic pancreatitis and that therefore
genetic variations in TRPV1 could modify the presence
and/or the phenotypical expression of chronic pancreati-
tis. The aim of our study was to investigate the genetic var-
iation of TRPV1  in Dutch chronic pancreatitis patients
and healthy controls.
Methods
Subjects
We enrolled patients diagnosed with chronic pancreatitis,
who visited the outpatient clinic of the Department of
Gastroenterology and Hepatology of the Radboud Uni-
versity Nijmegen Medical Centre in the Netherlands
between 1999 and 2008. The clinical diagnosis of chronic
pancreatitis was based on one or more of the following
criteria: presence of typical complaints (recurrent upper
abdominal pain, radiating to the back, relieved by leaning
forward or sitting upright and increased after eating), sug-
gestive radiological findings, such as pancreatic calcifica-
tions or pseudo cysts, and pathological findings
(pancreatic ductal irregularities and dilatations) revealed
by endoscopic retrograde pancreaticography or magnetic
resonance imaging of the pancreas before and after stimu-
lation with secretin. We collected data with special
emphasis on the cause of chronic pancreatitis. We speci-
fied for the cause of pancreatitis. Patients who had an esti-
mated intake of alcohol of more than 60 g (females) or 80
g (males) daily for more than two years were classified as
chronic pancreatitis of alcoholic origin. Hereditary pan-
creatitis was defined when chronic pancreatitis was
present in two or more family members [12]. Idiopathic
pancreatitis was diagnosed when precipitating factors
such as alcohol abuse, bile stones, trauma, medication,
infection, metabolic disorders, and a positive family his-
tory were absent. Patients with other causes of pancreati-
tis, such as anatomic or tropical, were classified as
miscellaneous causes.
Ethics
The study was conducted in accordance with the princi-
ples of the Helsinki Declaration and was approved by the
local medical ethics review committee. All subjects gave
their informed consent.
Genotyping
For genotyping, a venous blood sample from each subject
was collected. Genomic DNA was extracted from periph-
eral blood leukocytes by standard techniques. We selected
4 non-synonymous TRPV1 gene SNPs with a heterozygos-
ity rate exceeding 10%. Primers flanking the SNPs were
designed on the basis of publicly available nucleotide
sequence of human TRPV1 (Additional file 1). Amplifica-
tion was performed in a 25 μl mixture containing 200 ng
of genomic DNA 10 mM Tris-HCl (pH 9.0), 50 mM KCl,
0.1% Triton X-100, 0.25 mM dNTPs, 0.20 μM each
primer, 2.5 U Taq polymerase, and 1.5 mM MgCl2, except
the mixture of rs224534 which contained a concentration
of 2.0 mM MgCl2. The protocol consists of an initial dena-
turation at 95°C for 4 minutes, followed by 40 cycles of
denaturation at 95°C for 30 seconds, annealing at a par-
ticular temperature for each exon for 30 seconds as shown
in Additional file 1, and extension at 72°C for 30 seconds,
followed by a final extension at 72°C for 7 minutes.
To detect SNP rs222749 (c.271C>T) PCR products were
digested with Sau96I (New England Biolabs, Ipswich,
USA) resulting in the following fragments: C/C, 322 + 99
bp; C/T, 421 + 322 + 99 bp; T/T, 421 bp. SNP rs222747
(c.945C>G) was detected using BsaBI (New England
Biolabs, Ipswich, USA) digestion of the PCR products
resulting in the following fragments: C/C, 269 + 162 bp;
C/G, 431 + 269 + 162 bp; G/G, 431 bp. To detect SNP
rs224534 (c.1406C>T) PCR products were digested with
BsrI (New England Biolabs, Ipswich, USA) resulting in the
following fragments: C/C, 191 + 115 + 21 bp; C/T, 191 +
136 + 115 + 21 bp; T/T, 191 + 136 bp.
All digested products were subjected to electrophoresis on
a 3.5% pronarose MS-8 gel (Hispanagar, Burgos, Spain)
and detected by ethidium bromide.
SNP rs8065080 (c.1753A>G) was detected by direct
sequencing and analysed by the sequence facility of the
Radboud University Nijmegen Medical Centre in the
Netherlands (Additional File 2).
Statistical analysis
Frequency tables were provided for the distribution of the
4 studied SNPs and compared between cases and controls
by Pearson's chi-squared test (two-sided Fisher's exact test
was used in case values in any of the cells within the table
was below 10). We tested for Hardy-Weinberg equilib-
rium (HWE) among controls using a calculator available
on the internet [13].
Table 1: Demographic and clinical characteristics of chronic 
pancreatitis patients and healthy controls
Patients Controls P value
n 228 207
Age (mean, range) 47 (17-78) 39 (18-86) p = 0.002
Sex (male: female) 146:82 79:128 p < 0,001
Cause of chronic pancreatitis
Alcoholic 96 (42,1%)
Hereditary 14 (6,1%)
Idiopathic 100 (43,9%)
Miscellaneous 18 (7.9%)BMC Gastroenterology 2009, 9:97 http://www.biomedcentral.com/1471-230X/9/97
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Diplotypes were generated based on the 4 studied SNPs,
missing genes were imputed. The relative risk associated
with rare alleles was estimated as an odds ratio (OR) with
a 95% confidence interval (CI) with the most common
diplotype as a reference. For diplotypes that were only
present in either the patient population or healthy con-
trols, no odds ratios were calculated.
We used Haploview 4.0 software to construct a figure of
the linkage disequilibrium (LD) plot [14].
Results
Characteristics of patients and controls
Samples from a total of 435 subjects were included in our
study cohort. The clinical characteristics of the patients
and controls are shown in Table 1. The cohort of 228
patients with chronic pancreatitis included 146 male and
82 female patients and the mean age was 47 years (range
17-78 years). 42% of the patients had alcohol related
chronic pancreatitis. There were 207 healthy, unrelated
controls (79 male and 128 female) with a mean age of 39
(range 18-86 years). In the control group, participants
were significantly more often of female gender than in the
patient group and they were younger of age.
SNP
The allele frequencies of the 4 TRPV1  gene SNPs in
chronic pancreatitis patients and healthy controls are
shown in Table 2. There was no evidence that the geno-
type frequencies of the 4 SNPs among the chronic pancre-
atitis patients and healthy controls deviated from those
expected under Hardy-Weinberg equilibrium (P > 0.05),
except for one SNP (rs8065080) in chronic pancreatitis
patients. There was no significant difference in allele fre-
quency between chronic pancreatitis patients and healthy
controls.
Diplotype analysis
Based on the SNP distribution, 27 diplotypes (Additional
file 2 and Additional file 3) were generated which were
present in chronic pancreatitis patients and in controls, of
which 17 diplotypes were present in both groups. Diplo-
type CCCA/CCCA is most prevalent in both groups. This
was therefore considered as the reference in calculating
the odds ratios for the remaining diplotypes. Distribution
of diplotypes was not statistically significantly different
between patients and controls (Figure 2 and 3).
Discussion and conclusion
We considered genetic variants of TRPV1 as a candidate
gene for chronic pancreatitis, as we hypothesized that
TRPV1 could act as a modifier for chronic pancreatitis and
that therefore genetic variations in TRPV1 could modify
the presence and the phenotypical expression of chronic
pancreatitis. In this study, we investigated the association
between 4 SNPs in the TRPV1 gene and chronic pancrea-
titis in a large cohort of adult chronic pancreatitis patients.
We found that the genotypic distribution of none of these
4 SNPs was significantly different between the chronic
pancreatitis and control group. Furthermore, based on the
SNP distribution 17 diplotypes were generated. There was
no significant difference in distribution of diplotypes
between patients and controls.
Our study seems to accord with data from TRPV1 knock-
out animals. There, mice lacking TRPV1 were not pro-
tected against pancreatic inflammation induced by
cerulein. Because the knockout mice lack functional
TRPV1, it seems likely that they developed an alternate
Table 2: Allele frequencies of the 4 TRPV1 gene SNPs in chronic pancreatitis patients and healthy controls.
Alleles Patients Controls P value
rs222749 0.251
C/C wildtype 204 (89.5%) 189 (92.6%)
C/T heterozygote 24 (10.5%) 15 (7.4%)
T/T homozygote 0 0
rs222747 0.946
C/C wildtype 118 (52%) 106 (51.2%)
C/G heterozygote 86 (37.9%) 78 (37.7%)
G/G homozygote 23 (22.0%) 23 (11.1%)
rs224534 0.135
C/C wildtype 83 (39.1%) 65 (39.4%)
C/T heterozygote 91 (42.9%) 82 (49.7%)
T/T homozygote 38 (17.9%) 18 (10.9%)
rs8065080 0.512
A/A wildtype 85 (38.2%) 68 (35.0%)
A/G heterozygote 86 (38.7%) 86 (44.3%)
G/G homozygote 51 (23.0%) 40 (20.6%)BMC Gastroenterology 2009, 9:97 http://www.biomedcentral.com/1471-230X/9/97
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inflammatory response pathway that compensates for the
loss of TRPV1 signaling. However, compensation by other
receptors in this model could not be excluded. The inves-
tigators addressed TNFα as a potential candidate for the
compensatory response. This suggests that the role of
TRPV1 in the generation of pancreatitis is smaller than
anticipated on experimental data from other studies [15].
We should remember that this is a study on an acute pan-
creatitis model that does not reflect chronic pancreatitis.
The pathogenesis in acute pancreatitis is probably to some
extent dissimilar from chronic pancreatitis. Therefore, one
cannot extrapolate results from a secretagogue-induced
acute pancreatitis to chronic pancreatitis.
So far, the majority of case-control studies has focused on
the association between various TRPV1 gene SNPs, most
often rs222747 and rs8065080, and pain. One study
failed to identify a significant association between these
SNPs and cold/heat pain sensitivity in European Ameri-
cans [16]. Few studies have investigated the role of TRPV1
gene and human chronic pancreatitis. Further credibility
to the role of TRPV1 is provided by histochemistry studies
showing that TRPV1 is significant upregulated in human
chronic pancreatitis and in pancreatic cancer in compari-
son with patients with a normal pancreas. However,
TRPV1 expression was related to the intensity of pain
Diplotype distribution of chronic pancreatitis patients and healthy controls Figure 2
Diplotype distribution of chronic pancreatitis patients and healthy controls. Distribution of diplotypes in patients 
with chronic pancreatitis and healthy controls. The diplotypes are compared to the most prevalent diplotype CCCA/CCCA 
(reference).
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reported by cancer patients, but not to the intensity of
pain reported by chronic pancreatitis patients [17].
In our study, we investigated if TRPV1 polymorphisms are
associated with chronic pancreatitis, but we were actually
interested in the question whether "TRPV1 polymor-
phisms are associated with pain in patients with chronic
pancreatitis?". Our chronic pancreatitis group consisted of
patients experiencing pain varying from intermittent to
persistent and pain intensity ranging from disabling to no
pain or mild pain. We did not directly quantify pain,
which makes it difficult to study the exact correlation
between TRPV1 and pain due to chronic pancreatitis in
this population. It is very complex to investigate pain, due
to different levels of pain that patients experience, the use
of analgetic drugs and different pain scales. Moreover,
there are several confounding variables, such as depend-
ence of analgetic drugs and the use of alcohol or other nar-
cotic agents. However, since almost every patient with
chronic pancreatitis will experience pain during the course
of their disease, we lumped patients and investigated
TRPV1 in chronic pancreatitis patients from our cohort.
Xu and colleagues investigated functional effects of non-
synonymous SNPs in the human TRPV1 gene [18]. They
found that polymorphisms rs222747 and perhaps
rs222749 resulted in markedly increased abundance of
the variant TRPV1 protein at the level of whole-cell expres-
sion, and at the level of expression at the cell surface. The
increment in rs222747 mRNA level was probably not suf-
ficient to account for the marked change in protein expres-
sion.
Our study does have certain limitations. First, with our
current sample size, we were able to detect a 10 percent
difference with 80% power and a 0.05 two-sided signifi-
cance level. As a consequence, we cannot rule out the
existence of a smaller than 10% difference between
patients with pancreatitis and controls. The clinical rele-
vance of a difference below 10% is rather low. Moreover,
we combined 4 SNPs into diplotypes, making the study
even more robust excluding chance results.
Second, we have no insights in alcohol use in our healthy
controls. Recently other investigators found that the
TRPV1 receptor is activated by ethanol and has a role in
specific behavioral effects of ethanol [19]. Since a large
proportion of chronic pancreatitis patients developed
chronic pancreatitis as a result of liberal alcohol use, these
variables may likewise be important.
In conclusion, our results suggest that these four SNPs in
do not seem to modify the presence and phenotypical
expression of chronic pancreatitis.
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LD plot D'/LOD Figure 3
LD plot D'/LOD. Linkage disequilibrium (LD) plot across 
the TRPV1. The box at the top indicates the TRPV1 gene 
with the 4 investigated SNP's. The LD plot is based on the 
measure of D'. Each diamond indicates the pair wise magni-
tude of LD, with dark grey diamonds indicating strong LD (D' 
> 0.8) and light grey: uninformative. LD: linkage disequilib-
rium is the non-random association of alleles at two or more 
loci, not necessarily on the same chromosome. Linkage dise-
quilibrium describes a situation in which some combinations 
of alleles or genetic markers occur more or less frequently in 
a population than would be expected from a random forma-
tion of haplotypes from alleles based on their frequencies.
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